We Have to Learn to Do without Knowing Enough: Antieosinophilic Treatments for Severe Asthma
Open Access
- 1 January 2018
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 197 (1), 1-2
- https://doi.org/10.1164/rccm.201710-1970ed
Abstract
Interleukin.5 (IL.5) is the main eosinophilic cytokine that promotes the differentiation, \ud survival, and activation of eosinophils, which are the key inflammatory cells in severe \ud eosinophilic asthma .Thus, it is no surprise that anti.IL.5 pathways have been explored for several years for their ability to reduce eosinophilic inflammation and thus to improve the treatment of this diseaseThis publication has 15 references indexed in Scilit:
- New Anti-Eosinophil Drugs for Asthma and COPDChest, 2017
- The Biology of Eosinophils and Their Role in AsthmaFrontiers in Medicine, 2017
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe AsthmaNew England Journal of Medicine, 2017
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsThe Lancet Respiratory Medicine, 2016
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialThe Lancet, 2016
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsThe Lancet Respiratory Medicine, 2015
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Reslizumab for Poorly Controlled, Eosinophilic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaNew England Journal of Medicine, 2009
- A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2007